BusinessArbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)By Nasdaq OMXNov 13, 2017, 10:22 PM UTC
BusinessArbutus Announces Corporate Update and Third Quarter 2017 Financial ResultsBy Nasdaq OMXNov 2, 2017, 8:00 PM UTC
BusinessArbutus Announces Conference Call to Provide a Corporate Update and Third Quarter 2017 Financial ResultsBy Nasdaq OMXOct 31, 2017, 10:16 PM UTC
BusinessEmerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018By Nasdaq OMXOct 18, 2017, 11:01 AM UTC
BusinessRedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release CapsulesBy Nasdaq OMXAug 17, 2017, 11:00 AM UTC
BusinessMonsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for FarmersBy Nasdaq OMXAug 16, 2017, 12:30 PM UTC
BusinessChromaDex announces an exclusive worldwide patent license and research agreement with The Scripps Research Institute to identify the potential role of NIAGEN® in treating breast cancerBy Nasdaq OMXJun 12, 2017, 10:30 AM UTC
BusinessCURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.By Nasdaq OMXMar 21, 2017, 12:31 PM UTC
